Determination of serum fibrosis index in patients with chronic hepatitis and its relationship to histological activity index

Saudi Medical Journal

Volumn 30, Issue 5, 2009, Pages 638-646

  Elmetwally, Ibrahim M ^a   Elmahalaway, Abeer M ^a   Abuhashem, Sami H ^b   Ahmed, Adel M ^b  

^a Al Jedaani Hospital   (Saudi Arabia)

^b Alhayat Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ADOLESCENT; ARTICLE; AUTOIMMUNE HEPATITIS; BLOOD LEVEL; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MALE; NON INVASIVE MEASUREMENT; RELIABILITY;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 67649342208     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wang T, Wang B, Liu X. Correlation of serum markers with fibrosis staging in chronic viral hepatitis. Zhonghua Bing Li Xue Za Zhi 1998; 27: 185-190.
2. Friedman SL. Molecular regulation of hepatic fibrosis, an intergrate cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
3. Arthur MJ. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122: 1525-1528.
4. Grigorescu M. Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 2006; 15: 149-159.
5. Murata K, Ochiai Y, Akashio K. Polydispersity of acidic glycosaminoglycan components in human liver and the changes at different stages in liver cirrhosis. Gastroenterology 1985; 89: 1248-1257.
6. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology 2005; 42: 1437-1445.
7. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis, Hepatology 1981; 1: 431-435.
8. Desmet VJ. Scoring chronic hepatitis. J Hepatol 2003; 38: 382-386.
9. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004; 24: 89-97.
10. Lamberg S, Rothstein R. Laboratory manual of histology and cytology. 2nd ed. Westport (CT): AVI Publishing Co; 1979. p. 137-140.
11. Drury RA, Wallington EA. Carlton histological techniques. 5th ed. Oxford (UK): Oxford University Press; 1985. p. 239-295.
12. Hayat MA. Principles and techniques of electron microscopy: Biological application. 3rd ed. Boca Rotan (USA): CRC Press; 1989. p. 313-325.
13. Ingelfinger J, Mosteller F, Thibodeau L, Ware J. Biostatistics in clinical medicine. New York (NY): Mc Graw-Hill Inc; 1994.
14. Kasprzak A, Biczysko W, Adamek A, Zabel M. Morphological Lesions Detected by Light and Electron Microscopies in Chronic Type C Hepatitis. Pol J Pathol 2003; 54: 129-142.
15. Moat AP. Autoimmune chronic active hepatitis. Liver Disorders in Childhood chapter. Ist ed. Oxford (UK): Butterworth-Heinmann; 1994. p. 187.
16. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatoc fibrogenesis. Semin Liver Dis 2001; 21: 351-372.
17. Bravo AA, Sheth SG, Chopra S. Chronic Liver Disease? J Inter Med 2001; 242: 67-71.
18. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
19. Afdhal NH. Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to bloood tests. Hepatology 2003; 37: 972-974.
20. Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, et al. Hepascore: An acurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51: 1867-1873.
21. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classificatiob of chronic hepatitis: Diagnosis grading and staging. Hepatology 1994; 19: 1513-1520.
22. Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P, Fibrosis in patients with chronic hepatitis C: Detection and significance. Semin Liver Dis 2000; 20: 47-55.
23. David EK. The Liver Biopsy in Chronic Hepatitis C: A View from the Other Side of the Microscope. Semin Liver Dis 2005; 25: 52-64.
24. McMaho BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135: 759-768.
25. Theise ND. Liver biopsy assessment in chronic viral hepatitis: A personal, practical approach. Mod Pathol 2007; (20 Suppl 1): S3-S14.
26. Arthur MJP. Fibrosis an matrix degradation. Digestion 1998; 59: 376-380.
27. Gressner AM. The cell biology of iver fibrogenesis-an imbalance of profiferation, growth arrst and apoptosis of myofibroblast. Cell Tissue Res 1998; 29: 447-452.
28. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003; (38 Suppl): S38-S53.
29. Meuleman P, Libbrecht L, Wieland S, De Vos R, Habib N, Kramvis A, et al. Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. J Virol. 2006; 80: 2797-2807.
30. Taalat MM, Ibrahim SE, Nageh M. Utratructural study of the liver and kidney following maximum therapeuti dose of omeprazole administration in rats. Benha Medical Journal 1998; 15: 373-388.
31. Yanchun Li, Darren F. Boehning, Ting Qian, Vsevolod L. Popov and Steven A. Weinman. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. The FASEB Journal 2007; 21: 2474-2485.
32. Popper H. Clinial patholoic correlation in viral hepatitis. The effect of the virus on the liver. Am J Pathol 1975; 81:609-628.
33. Jaatinen P, Saukko P, Sarviharju M, Kiianmaa K, Hervonen A. Effects of long - life ehtanol consumption on the ultrastructure & lipopigmentation of rat heart. Acohol 1994;29:269-282.
34. Svoboda D, Grady H, Azarnoff D. Microbodies in experimentally altered cells. J Cell Biol 1976;35:127-152.
35. Mego JL, Cain JA. The effect of carbon tetrachloride on lysosome function in kidneys and livers of mice. Biochim Biophys Acta 1973: 28: 343-345.
36. Plevris JN, Haydon GH, Simpson KJ, Dawkes R, Ludlum CA, Harrison DJ, et al. Serum hyaluronan - a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12: 1121-1127.
37. Saltik-Temizel IN, Koçak N, Ozen H, Demir H. Serum hyaluronic acid concentrations in children with cirrhosis. Indian J Gastroenterol 2004; 23: 129-130.
38. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 1996; 11: 459-465.
39. Guéchot J, Serfaty L, Bonnand AM, Chazouillères O, Poupon RE, Poupon R. Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000; 32: 447-452.
40. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Post-prandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med 1998; 37: 568-575.
41. Pontinha N, Pessegueiro H, Barros H. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999; 59: 343-347.
42. Balistreri WF, Reg R. Liver function. In: Burtis CA, editor. Tietz Textbook of Clinical Chemistry. 4th ed. Philadelphia (PA): W. B. Saunders; 1996. p. 539-568.
43. Kelly DA. Textbook of diseases of liver and biliary system in children. Massachusetts (UK): Blackwell; 1999. p. 97-123.
44. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M, et al. Serum hyaluronate reflects hepatic sinusoidal capillarization. Gastroenterology 1993; 105: 475-481.
45. Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188-200.
46. Gibson PR, Fraser JR, Colman JC, Jones PA, Jennings G, Dudley FJ. Change in serum hyaluronan: A simple index of short-term drug-induced changes in hepatic sinusoidal perfusion. Gastroenterology 1993; 105: 470-474.